Jiangsu Lianhuan Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 600513?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,500	0.000525%
Public Companies	3,752,073	1.31%
Institutions	16,948,289	5.94%
Private Companies	113,884,816	39.9%
General Public	150,869,592	52.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
39.9%	Jiangsu Jinmao Chemical & Pharmaceutical Group Co., Ltd.	113,884,816	CN¥1.2b	1.26%	no data
1.31%	China National Medicines Corporation Ltd.	3,752,073	CN¥39.0m	0%	no data
1.06%	Gfund Management Co., Ltd.	3,038,200	CN¥31.6m	0%	0.12%
0.76%	CITIC Securities Company Limited, Asset Management Arm	2,167,247	CN¥22.5m	0%	0.02%
0.7%	Shanghai Yiding Investment Management Co., Ltd.	2,000,000	CN¥20.8m	0%	no data
0.57%	Everbright Pramerica Fund Management Co. Ltd.	1,626,800	CN¥16.9m	0%	0.15%
0.54%	China Merchants Fund Management Company Ltd.	1,553,800	CN¥16.2m	0%	0.01%
0.5%	China International Capital Corporation Hong Kong Asset Management Limited	1,413,296	CN¥14.7m	0%	0.08%
0.41%	Everbright Asset Management Co., Ltd.	1,180,704	CN¥12.3m	0%	0.15%
0.34%	Morgan Stanley, Investment Banking and Brokerage Investments	957,680	CN¥10.0m	0%	no data
0.31%	Barclays PLC Private Banking & Investment Banking Investment	886,307	CN¥9.2m	0%	no data
0.28%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	810,055	CN¥8.4m	0%	no data
0.26%	China National Petroleum Corporation, Enterprise Annuity Plan	733,900	CN¥7.6m	0%	0.56%
0.088%	Broad Asset Management Co., Ltd	251,400	CN¥2.6m	0%	0.02%
0.042%	Baoying Fund Management Co. Ltd.	120,000	CN¥1.2m	0%	0.01%
0.033%	China Universal Asset Management Company Ltd.	94,900	CN¥987.1k	0%	no data
0.009%	CIB Fund Management Co., Ltd	25,700	CN¥267.2k	0%	no data
0.0073%	E Fund Management Co., Ltd.	20,700	CN¥215.2k	0%	no data
0.0071%	Wanjia Asset Management Co., Ltd.	20,300	CN¥211.1k	0%	no data
0.0058%	China Asset Management Co. Ltd.	16,500	CN¥171.6k	0%	no data
0.0053%	Huatai-PineBridge Fund Management Co., Ltd.	15,000	CN¥155.9k	0%	no data
0.0035%	SWS MU Fund Management Co., Ltd.	9,900	CN¥103.0k	0%	no data
0.0006%	Harvest Fund Management Co. Ltd.	1,700	CN¥17.8k	0%	no data
0.00056%	China Fund Management Co., Ltd.	1,600	CN¥16.6k	0%	no data
0.00053%	Chunyuan Wang	1,500	CN¥15.7k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 18:42
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution